Hetrombopag |
| Catalog No.GC69221 |
Hetrombopag est un agoniste efficace du récepteur de la thrombopoïétine. Hetrombopag est efficace et bien toléré, avec une sécurité contrôlable. Hetrombopag a le potentiel d'être étudié pour les cas d'immunothrombocytopénie.
Products are for research use only. Not for human use. We do not sell to patients.
Cas No.: 2114365-78-3
Sample solution is provided at 25 µL, 10mM.
;)
,-1-7$$$37316672.jpg');)
;)
;)
$$$36806353.jpg');)
;33(7)%EF%BC%9A546-561$$$37156877.jpg');)
;)
;)
;)
%201124-1138.$$$35908550.jpg');)
%20766-780.$$$37100057.jpg');)
%20418-432.$$$36893736.jpg');)
%EF%BC%9A-240-255.$$$35108512.jpg');)
533-545$$$36543525.jpg');)
%201-13.$$$36600053.jpg');)
;)
Review for Hetrombopag
Average Rating: 5 (Based on Reviews and 30 reference(s) in Google Scholar.)
Review for Hetrombopag
GLPBIO products are for RESEARCH USE ONLY. Please make sure your review or question is research based.
Required fields are marked with *